论文部分内容阅读
目的探讨布地奈德混悬液雾化吸入治疗急性呼吸道感染引起的频繁剧烈咳嗽的疗效。方法 88例患儿随机分成观察组和对照组各44例。观察组:给予抗炎、止咳、化痰治疗+雾化吸入布地奈德混悬液,1mg/次,1日2次,1～3d;对照组:给予抗炎、止咳、化痰治疗﹢雾化吸入盐酸氨溴索,7.5mg/次,1日2次,1～3d。观察评价布地奈德雾化吸入治疗的疗效。结果观察组显效32例,有效8例,无效4例。对照组显效6例,有效10例,无效28例。观察组有效率明显高于对照组(90.9%vs36.4%,P<0.05)。2组均无不良反应发生。结论布地奈德混悬液雾化吸入治疗能够使急性呼吸道感染引起的频繁剧烈咳嗽症状很快缓解。
Objective To investigate the efficacy of inhalation of budesonide suspension in the treatment of frequent severe cough caused by acute respiratory infection. Methods 88 cases of children were randomly divided into observation group and control group of 44 cases. Observation group: given anti-inflammatory, cough, phlegm therapy + inhalation of budesonide suspension, 1mg / time, 1 day 2 times, 1 ~ 3d; control group: given anti-inflammatory, cough, phlegm therapy + fog Ambroxol hydrochloride inhalation, 7.5mg / time, 1 day 2 times, 1 ~ 3d. Observation and evaluation of budesonide inhalation therapy efficacy. Results The observation group 32 cases markedly effective in 8 cases, 4 cases were ineffective. The control group markedly effective in 6 cases, effective in 10 cases, ineffective in 28 cases. The effective rate in observation group was significantly higher than that in control group (90.9% vs36.4%, P <0.05). No adverse reactions occurred in both groups. Conclusions Budesonide suspension nebulization can relieve frequent severe cough caused by acute respiratory infection.